Affimed (AFMD) EBITDA US GAAP (year values) |
|||||||||
2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, € | ? | -64 006 000 | -64 006 000 | -86 637 000 | -86 637 000 | -103 810 000 | -69 820 000 | ||
Changes by years, y/y, % | +87% | 0% | +35% | 0% | +20% | +40.6% |
Affimed. EBITDA US GAAP, €
Affimed. EBITDA US GAAP, changes, %
Affimed. EBITDA US GAAP, sum by quarters, €
Affimed (AFMD) EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2024Q1 | 2023Q4 | 2024Q2 | 2024Q1 | LTM ? | |||
EBITDA, € | ? | -23 565 000 | -17 065 000 | -20 825 000 | -14 865 000 | -17 065 000 | -69 820 000 | |
Changes by years, y/y, % | +26% | -25% | -48% | |||||
Changes by quarters, q/q, % | -18% | -28% | +22% | -29% | +15% |